Dec 2020

HeartForce CAD Report – Seismocardiography: A Reliable Screening Method to Detect Coronary Artery Disease

HeartForce is pleased to present a report of its latest studies and results for identifying patients with coronary artery disease (CAD) using seismocardiography (SCG). The findings of this study tested the performance of HeartForce SCG technology in identifying patients with CAD compared to other methods, including ECG stress test and coronary computed tomography angiography (CCTA).

Read Study (PDF)

Back to News

Need to get in touch with the team? We’re all ears. Contact us today.

This website (“Web Site”) is offered to you by HeartForce Medical Inc. (HeartForce), Vancouver, BC, Canada.

The following Terms of Use govern your access and use of this Web Site and its service. Also, specific terms and conditions may apply to specific content, data, materials, or information contained on or available through this Web Site (the “Content”) and to specific content, data, materials, or information you may upload, submit and/or publish to the Web Site (“User Content”) or transactions concluded through this Web Site.